A Sequential Single and Multiple Ascending Dose (SAD/MAD) Study of SK10 Powders in Healthy Adult Subjects

Clinical trial NCT06026397 · COMPLETED

Trial details

NCT number: NCT06026397
Sponsor: Guangzhou Zhiyi Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Diarrhea

Start date: 2023-08-01
Primary completion: 2024-02-11
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.